Literature DB >> 16133432

[Anorexic and bulimic eating disorders].

M M Fichter1.   

Abstract

Anorexic and bulimic eating disorders today are rather frequent in adolescent girls and young women of developed industrial countries. News media frequently report such patients, and lay people are interested. For scientists, it is not easy to explain the etiology and pathophysiology of these eating disorders. Clinically, treatment is a challenge. General risk factors for the development of anorexic and bulimic eating disorders are (1) female gender, (2) adolescence, and (3) living in an industrial country. Special risk factors are (1) obesity or mental disorders (eating, depression, substance use), (2) premorbid characteristics (early menarche, childhood obesity, anxiety disorder, low self-esteem, and perfectionism), and (3) premorbid stresses. Biological and sociocultural factors and personally threatening experiences all play a role in the etiology. Especially in early phases of the illness, affected patients do not appear to suffer, are reluctant to admit symptoms, and may avoid necessary treatment. Progress has recently been made in the understanding and treatment of anorexic and bulimic eating disorders.

Entities:  

Mesh:

Year:  2005        PMID: 16133432     DOI: 10.1007/s00115-005-1976-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

1.  Practice guideline for the treatment of patients with eating disorders (revision). American Psychiatric Association Work Group on Eating Disorders.

Authors: 
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

2.  Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa.

Authors:  A W Bergen; M B M van den Bree; M Yeager; R Welch; J K Ganjei; K Haque; S Bacanu; W H Berrettini; D E Grice; D Goldman; C M Bulik; K Klump; M Fichter; K Halmi; A Kaplan; M Strober; J Treasure; B Woodside; W H Kaye
Journal:  Mol Psychiatry       Date:  2003-04       Impact factor: 15.992

3.  Twelve-year course and outcome of bulimia nervosa.

Authors:  Manfred M Fichter; Norbert Quadflieg
Journal:  Psychol Med       Date:  2004-11       Impact factor: 7.723

4.  Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.

Authors:  W H Kaye; T Nagata; T E Weltzin; L K Hsu; M S Sokol; C McConaha; K H Plotnicov; J Weise; D Deep
Journal:  Biol Psychiatry       Date:  2001-04-01       Impact factor: 13.382

Review 5.  Eating disorders.

Authors:  Christopher G Fairburn; Paul J Harrison
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

6.  Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa.

Authors:  Steven Grinspoon; Lisa Thomas; Karen Miller; David Herzog; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.